N/A
N=83
The Hospice Advanced Dementia Symptom Management and Quality of Life Trial
Dementia
Bottom Line
View on ClinicalTrials.gov: NCT03681119 ↗Enrolled (actual)
83
Serious AEs
45.5%
Results posted
Jul 2020
Primary outcome: Primary: Percentage of Hospice IDT Members Who Complete Required Education and Training — 92 percentage of participants
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Dementia symptom management at home hospice edition (Behavioral); Education and Training (Behavioral)
- Age
- Adult, Older Adult · 50+ yrs
- Sex
- All
- Sponsor
- NYU Langone Health
- Primary completion
- Jun 2019
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Percentage of Hospice IDT Members Who Complete Required Education and Training |
92 | — |
Summary
Alzheimer's Disease and Related Disorders (dementia) are a group of serious life limiting illness that cause significant challenges to our public health system, with significant illness burden for both the person with dementia and the caregiver. At the end of life, over 230,000 persons with dementia annually are cared for in hospice, yet hospice agencies are ill prepared to care for this population and often resort to inappropriate pharmacologic measures such as antipsychotics that reduce quality of life rather than improve it. This study will therefore through its two phases refine and then implement, using a pragmatic stepped wedge trial design, the Dementia Symptom Management at Home Program Hospice Edition, with the goal improving quality of care for the person with dementia and their caregiver, reducing antipsychotic use, and increasing bereaved caregiver satisfaction in the hospice setting.
Eligibility Criteria
Inclusion Criteria
- Must have dementia as primary diagnosis for admission to hospice
- Must be newly admitted to a participating hospice
- Must be 50 years or older
Clinicians:
- Must be a skilled clinician or home health aide who provides care through an eligible home health agency
- Must be 18 years or older
Exclusion Criteria
Persons with Dementia:
- None
Clinicians:
- None
Data sourced from ClinicalTrials.gov (NCT03681119). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.